000

DONGSUNG PHARM

No trades
See on Supercharts
Market capitalization
‪123.52 B‬KRW
‪−2.07 B‬KRW
‪88.59 B‬KRW
‪15.17 M‬
Beta (1Y)
0.23

About DONGSUNG PHARM

CEO
Yang-Gu Lee
Headquarters
Seoul
Employees (FY)
343
Founded
1957
ISIN
KR7002210003
FIGI
BBG000BGYFG3
Dongsung Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceuticals. It operates through the Pharmaceutical and Cosmetic business divisions. Its products include general and special medicines such anti-rheumatic and anti-inflammatory analgesics, anti-inflammatory enzymes, cardiovascular system, gastrintestinal drugs, antispasmodic agents, respiratory agents, anti-histamine, dematologicals, antibiotics, antidiarreals, antifungals, oral hypoglycemic agents, hormones, and tranquillizers. The company was founded by Sun-Kyu Lee on November 25, 1957 and is headquartered in Seoul, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 002210 is 5250 KRW — it has decreased by 1.13% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DONGSUNG PHARM stocks are traded under the ticker 002210.
002210 stock is 5.78% volatile and has beta coefficient of 0.23. Check out the list of the most volatile stocks — is DONGSUNG PHARM there?
Yes, you can track DONGSUNG PHARM financials in yearly and quarterly reports right on TradingView.
002210 stock has fallen by 2.42% compared to the previous week, the month change is a 3.55% rise, over the last year DONGSUNG PHARM has showed a 10.41% decrease.
002210 net income for the last quarter is ‪−1.99 B‬ KRW, while the quarter before that showed ‪−44.65 M‬ KRW of net income which accounts for ‪−4.35 K‬% change. Track more DONGSUNG PHARM financial stats to get the full picture.
Today DONGSUNG PHARM has the market capitalization of ‪121.42 B‬, it has decreased by 1.26% over the last week.
No, 002210 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 002210 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DONGSUNG PHARM stock right from TradingView charts — choose your broker and connect to your account.
002210 reached its all-time high on Sep 5, 2018 with the price of 49300 KRW, and its all-time low was 760 KRW and was reached on Oct 28, 2008.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 343.00 employees. See our rating of the largest employees — is DONGSUNG PHARM on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DONGSUNG PHARM technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DONGSUNG PHARM stock shows the sell signal. See more of DONGSUNG PHARM technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DONGSUNG PHARM EBITDA is ‪2.65 B‬ KRW, and current EBITDA margin is 2.98%. See more stats in DONGSUNG PHARM financial statements.